<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82591">
  <stage>Registered</stage>
  <submitdate>10/02/2008</submitdate>
  <approvaldate>18/03/2008</approvaldate>
  <actrnumber>ACTRN12608000139370</actrnumber>
  <trial_identification>
    <studytitle>Quality of life assessment in pulmonary arterial hypertension</studytitle>
    <scientifictitle>Quality of life assessment in pulmonary arterial hypertension.  The validation and investigation of responsiveness of the Cambridge Pulmonary Hypertension Outcome Review in an Australian and New Zealand population with pulmonary arterial hypertension</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Quality of life</healthcondition>
    <healthcondition>Pulmonary arterial hypertension</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is a quality of life (QoL) measure with three subscales: symptoms, activities and QoL. This study aims to validate the CAMPHOR in Australia and New Zealand. Firstly, interviews will be conducted to ensure the language and content of the CAMPHOR is appropriate for our population. Subsequently, test-retest reliability of the CAMPHOR will be performed at several hospitals within Australia and New Zealand.</interventions>
    <comparator>N/A</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Quality of life questionnaire (CAMPHOR) scores</outcome>
      <timepoint>test, retest (2 weeks)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of pulmonary arterial hypertension</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Non-English speaking
Major psychological or mood disorders
Cognitive impairment that precludes informed consent and ability to complete questionnaires and follow instructions
Severe musculoskeletal limitations that impair exercise performance
Severe neurological limitations
Co-morbid cardiovascular and/or pulmonary disease</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Psychosocial</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/03/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>130</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>6000</postcode>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>4710</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Curtin University of Technology</primarysponsorname>
    <primarysponsoraddress>Kent Street
Bentley
Perth Western Australia 6102</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Western Australian Heart and Lung Transplant Foundation</fundingname>
      <fundingaddress>PO Box 110 
Hillarys Western Australia 6926</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Bayer Schering Pharma</fundingname>
      <fundingaddress>875 Pacific Highway
Pymble New South Wales 2073</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Perth Hospital</sponsorname>
      <sponsoraddress>Wellington Street
Perth Western Australia 6000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the only available questionnaire specifically developed for patients with pulmonary arterial hypertension (PAH).  The CAMPHOR has been used in the United Kingdom to measure quality of life (QoL) in patients with PAH.  This study aims to investigate whether the CAMPHOR is a useful questionnaire for an Australian and New Zealand group of patients with PAH, as well as to see whether it more accurately reflects changes in QoL in this group when compared to a widely used generic QoL questionnaire (the Short Form 36). Measuring QoL is important outcome measure to determine the effectiveness of treatment from the patients perspective.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Royal Perth Hospital
Wellington Street
Perth Western Australia 6000</ethicaddress>
      <ethicapprovaldate>18/01/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Curtin University of Technology Human Research Ethics Committee</ethicname>
      <ethicaddress>GP Box U1987
Perth Western Australia 6845</ethicaddress>
      <ethicapprovaldate>8/02/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Louise Ganderton</name>
      <address>School of Physiotherapy
Curtin University of Technology
GPO Box U1987
Perth Western Australia 6845</address>
      <phone>+61 8 92242076</phone>
      <fax />
      <email>louise.ganderton@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Louise Ganderton</name>
      <address>School of Physiotherapy
Curtin University of Technology
GPO Box U1987
Perth Western Australia 6845</address>
      <phone>+61 8 92242076</phone>
      <fax />
      <email>louise.ganderton@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Louise Ganderton</name>
      <address>School of Physiotherapy
Curtin University of Technology
GPO Box U1987
Perth Western Australia 6845</address>
      <phone>+61 8 92242076</phone>
      <fax />
      <email>louise.ganderton@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>